The question of whether dyskinesia of the type found in tardive dyskinesia (TD) related to schizophrenia has a neurodevelopmental background was studied in a sample of 60 younger schizophrenia patients (mean age 38 years) and 21 of their non-ill siblings. TD-like dyskinesia was studied in relation to selected risk factors in the patients, and to neurological abnormality and parkinsonism in both patients and siblings. One or more signs of TD-like dyskinesia In patients were predicted by male gender, a history of obstetric complications, shorter illness duration, and shorter neuroleptic exposure. One or more signs of TD-like dyskinesia were found in 28.5 percent of the siblings and tended to be associated with neurological abnormality. Little co-occurrence of TD-like dyskinesia was found in the sibling and the patient in the same family. Patients' TD-like dyskinesia was significantly associated with hard neurological signs (independent of involuntary movements) but not with soft signs or primitive reflexes per se. TD-like dyskinesia showed a significant positive relationship to parkinsonism in patients. TD-like dyskinesia in younger schizophrenia patients appears to have neurodevelopmental antecedents and seems to represent one aspect of the total neurological abnormality associated with schizophrenia.
After more than 3 decades of intensive scientific study, the basic nature of TD co-occuring with schizophrenia remains an enigma (Newman 1991; Pourcher et al. 1995) , and it is still unknown why some patients with schizophrenia develop TD and others do not (Newman 1991; Waddington et aL 1995; Egan et al. 1997 ). Many authors (Bartels et al. 1985; Gureje 1987; Waddington 1987; Youssef and Waddington 1988; O'Callahan et al. 1990a; King et al. 1991; McCreadie et al. 1992a; van Os et al. 1997 ) have suggested the possibility that dyskinesia (whether "spontaneous" or medication induced) is an expression of underlying brain pathology, possibly reflecting a developmentally compromised central nervous system (CNS). Relatively few empirical studies have tested this hypothesis, and the results to date are inconsistent concerning whether TD-like movement disorders in schizophrenia patients are systematically related to markers of early neurodevelopmental disturbances such as minor physical anomalies (MPAs) and obstetric complications (OCs) (table 1).
Some of tiiis empirical inconsistency might be due to methodological issues. For example, all of the studies of the relationship between TD and OCs have used mothers' (or relatives') retrospective recall as a source of OC information, and all except Pourcher and colleagues (1995) have used the Lewis and Murray scale (Lewis et al. 1989) for scoring OCs. The veridicality of maternal retrospective reports of OCs has been the subject of controversy (O'Callaghan et al. 1990fc; Cantor-Graae et al. 1998a) , and studies have questioned die optimalness of die Lewis and Murray OC scale to discriminate between OC histories for schizophrenia patients and those of controls (McNeil et al. 1994a) and to define relationships between OCs and other characteristics of schizophrenia patients (McNeil et al. 1997; Smith et al. 1998) . The use of OC data based on prospectively recorded medical records and scored by a more extensive and discriminating OC scale (e.g., McNeil and Sjbstrfjm 1995) might well yield other findings concerning the relationship between TD-like dyskinesia and OC history.
The previous findings regarding TD-like dyskinesia and family history (FH) of psychosis (a proxy for genetic influence) are similarly varied ( Note.-MPAs = minor physical anomalies; negative = significantly negative relationship; no = no significant relationship; OCs = obstetric complications; positive = significantly positive relationship; TD = tardtve dysklnesia.
of signs of movement disorders in the non-ill first degree relatives of schizophrenia patients even in childhood (McNeil et al. 1993) suggests that these TD-like dyskinesias (tremor, choreatic/choreiform movements) may have an early developmental nature, based on genetic or shared environmental factors. Yassa and Ananth (1981) found perfect within-family concordance on presence versus absence of TD in five sibling pairs of patients and suggested the possible existence of "familial TD." In contrast, McCreadie and colleagues (1996) observed varying degrees of concordance and discordance for TD-like dyskinesia across four pairs of patients with schizophrenia and their elderly parents without schizophrenia. Spontaneous TD-like dyskinesia is known to appear in some older individuals in the absence of both psychosis and neuroleptic exposure (Chiu et al. 1993; McCreadie et al. 1996) , and such dyskinesia might, by inference, appear with similar spontaneity in older patients with schizophrenia. Indeed, increased age is the factor most consistently found to be associated with TD in schizophrenia patients (e.g., O'Callaghan et al. 1990o; Khot and Wyatt 1991; Newman 1991; Pourcher et al. 1995; Egan et al. 1997) .
We reasoned that an efficient strategy in investigating the possible early neurodevelopmental background factors for TD-like dyskinesia might be to study this in younger patients and their non-ill relatives. Furthermore, as suggested by others Pourcher et al. 1995) , we reasoned that we might investigate a milder degree of TD-like symptoms (e.g., presence vs. absence of one or more signs of TD-like dyskinesia) than that specified in the stricter Schooler and Kane (1982) criteria. We used this approach in the current study.
A second major issue pursued in this study concerns whether TD-like dyskinesia is a separate phenomenon or represents an integral component of the neurological abnormality present in schizophrenia (Woods et al. 1986; Rubin et al. 1994; Chen et al. 1996) . The empirical results to date are inconsistent concerning the possible relationship between TD-like dyskinesia and other forms of neurological abnormality, as well as the relationship between TD-like dyskinesia and parkinsonism (table 2) . However, die study of a milder form of TD-like dyskinesia than that specified in the Schooler-Kane criteria might yield increased understanding of these relationships. For example, Manschreck and colleagues (1990) found a strong positive relationship between abnormal involuntary movements (milder than those defining TD) and abnormality on voluntary motor performance. This fits well with Pourcher and colleagues' (1995) finding that neurological abnormality is strongly related both to mild dyski- Kolakowska et al. 1985 Wegrteretal. 1985 Gureje 1987 Marsalek et al. 1988 King etal. 1991 Gupta etal. 1995 Pourcher et al. 1995 Primitive reflexes Youssef and Waddington 1988 Barnes etal. 1995 Parkinsonism Chouinard et al. 1979 Toenniessen et al. 1985 Kucharski etal. 1987 Gerlach1988 Gerlachetal. 1993 Elliott etal. 1994 van Harten et al. 1997 No Note.-negative = significantly negative relationship; no = no significant relationship; positive = significantly positive relationship; TD = tardive dyskinesia.
nesia and to more serious TD that fulfills the SchoolerKane criteria. Their study also found that both mild dyskinesia and classical TD bear an equally strong relationship to early occult brain damage (i.e., perinatal trauma and childhood brain injuries). Further progress might be made by determining not only whether TD-like dyskinesia and neurological abnormality relate to one another but also what types of neurological abnormality significantly characterize schizophrenia patients with TD-like dyskinesia, as compared with patients without such dyskinesia. The aims of this study were (1) to investigate whether the occurrence of one or more signs of TD-like dyskinesia is related to early developmental factors (MPAs, OCs, FH of psychosis, head circumference at birth) and other risk factors (age, gender, neuroleptic exposure, illness duration), (2) to determine the nature of TD-like dyskinesia's possible relationships to neurological abnormality and parkinsonism in schizophrenia patients, (3) to study whether signs of TD-like dyskinesia appear in the nonpsychotic siblings of schizophrenia patients and are related to neurological abnormality in the siblings, and (4) to determine whether a familial relationship exists between TD-like dyskinesia in the patient and the sibling in the same family.
These questions were investigated in a sample of 60 younger schizophrenia patients and 21 of their nonpsychotic siblings (mean age 38 years in both groups). These patients have been found to have increased rates of neurological abnormality (Ismail et al. 19986) in adulthood, as well as an increased history of early trauma and maldevelopment in the form of OCs (Cantor-Graae et al. 2000) , MPAs , and reduced head circumference at birth . These patient characteristics provide the opportunity to investigate the relationship between TD-like dyskinesia and both early developmental deviation and adult neurological abnormality. The nonpsychotic siblings have also demonstrated significantly increased rates of neurological abnormality (Ismail et al. 1998Z>) and MPAs ). The investigation of this small sample of neuroleptically naive siblings may thus be especially illustrative concerning whether TD has a "familial" component, independent of both a schizophrenic disease process and neuroleptic exposure.
Method
The subjects were 60 patients and 21 of their siblings (at most, one sibling per family). The patients (44 men and 16 women) were recruited from the centralized psychiatric facilities in Malm5, Sweden. They fulfilled the criteria for a DSM-III-R (American Psychiatric Association 1987) diagnosis of schizophrenia, were born in Scandinavia in or after 1941, and had no history of psychoactive substance abuse (as defined by DSM-III-R criteria), head trauma, or major neurological or somatic disorder with neurological components (e.g., multiple sclerosis). Mean duration of illness since first psychotic episode was 14.8 years, and mean age at time of study was 38.2 years (table 3) . Age did not differ significantly for male versus female patients (f = 1.53, df = 58, nonsignificant [ns]). All subjects were Caucasian. Informed consent of the participants was obtained after the procedures had been fully explained.
An attempt was made to study one non-ill sibling for each patient. Twenty patients did not have nonpsychotic siblings available for inclusion, siblings for 9 patients declined to participate, and siblings for 10 patients did not respond to the request to participate. The 21 siblings who did participate (mean age = 37.9 years, standard deviation [SD] = 8.8, range = 17-51, 11 of 21 younger than 40 years old and 19 of 21 younger than 50 years old) had no history of psychotic or affective disorder, head trauma, neurological disorder, somatic disorder with neurological components, or psychoactive substance abuse per DSM-III-R criteria. Participating siblings were interviewed by the Structured Clinical Interview for DSM-III-R (Spitzer et al. 1989 ) for schizotypal personal- Table 3 . Characteristics of the patient sample (n = 60) ity disorder. While a few siblings had isolated symptoms, no sibling fulfilled the complete DSM-III-R criteria for the disorder. All of the siblings were neuroleptic-naive.
Tardivelike dyskinesia was measured for both patients and siblings using the Tardive Dyskinesia Rating Scale by Simpson and colleagues (1979) . This scale consists of 43 items divided into four subsections: face (14 items), neck and trunk (6 items), upper and lower extremities (6 items each), and the entire body (2 items), with 9 additional write-in items for TD signs observed by the examiner but not already listed in the scale. Each item is rated on a six-point scale: 1 = absent, 2 = possibly present, 3 = mild severity, 4 = moderate severity, 5 = moderately severe, and 6 = very severe. A score of 43 on the total scale thus represents a total absence of TD-like dyskinesia in the subject, while scores above that represent one or more signs of TD-like dyskinesia. Variables representing total TD-like dyskinesia score as well as the absence or presence of one or more signs of TD-like dyskinesia (severity level 2 or higher) were used in data analyses. Furthermore, secondary analyses studied the relationship between the risk factors and TD defined according to the stricter Schooler-Kane criteria (1982) (signs of mild severity in at least two body areas or at least one sign of moderate severity). TD scale data were available for 59 of the 60 patients and all 21 siblings.
Parkinsonism was measured using the rating scale for Extrapyramidal Side Effects (EPRS) (Simpson and Angus 1970) . This scale included 10 items, each item being rated on a five-point scale: 0 = normal, 1 = slight, 2 = moderate, 3 = marked, and 4 = extreme. Parkinsonism was represented as absent (0 on all items) or present (1 or higher on at least one item), as well as by the total EPRS score. Parkinsonism scores were available for 58 of the 60 patients and all 21 siblings.
The cross-sectional rather than longitudinal nature of the study did not permit investigation of possible fluctuations in the TD-like dyskinesia and parkinsonism symptoms over time, and the data for these variables represented the condition of the patients at the time of investigation.
Interjudge reliability between the examiner (B.I.) and another physician (E. Schubert, M.D.) was tested through independent assessment of 10 hospitalized patients with psychosis. This test showed a high level of interjudge agreement on total scores for both the TD and parkinsonism scales (intraclass correlation coefficients, r = 0.% for both scales).
Putative Etiological Variables. MPAs were assessed for each subject using an extended and standardized scale consisting of 41 items representing MPAs in six body areas (eyes, ears, mouth, global head, hands, and feet), as described in detail elsewhere . Data analyses used the total scores for MPAs in all body areas combined, as well as Waddington and colleagues' (1995) "anomalies distribution index" (i.e., MPA scores for the head [eyes + ears + mouth + global head] minus the MPA scores for the periphery [hands + feet], divided by total MPAs).
OCs. OC history and head circumference at birth were obtained blindly from the obstetric records systematically compiled at the time of the patients' and siblings' gestation and birth (Cantor-Graae et al. 2000) . Obstetric records could be found for 54 of the 60 patients and 19 of the 21 siblings (missing records were due to delivery at home or in Finland). The records for the patients and their siblings were compiled by a research assistant and subsequently studied (by E.C-G. and T.F.M.) in a series of records, including those for demographically similar control cases from the same delivery series as the patients and siblings. The OCs identified in these records were scored according to the McNeil-SjostrSm Scale for Obstetric Complications (McNeil and SjostrOm 1995) . This scale assesses an extensive range of OCs according to a sixpoint scale of severity. The OC score chosen for analysis a priori was the total number of OCs for the entire reproduction, consisting of the number of pregnancy complications at severity level 3 ("potentially harmful or relevant") or higher, plus labor-delivery and neonatal complications at severity level 4 ("clearly harmful or relevant") or higher. Previous research showed this score to discriminate schizophrenia patients from comparison cases (McNeil et al. 19946) , and this was also true for the current sample of patients (Cantor-Graae et al. 2000) . All assessment of obstetric records and scoring of OCs was done blindly with respect to the individual's group status (i.e., patient, sibling, or control) and to other characteristics of the cases, including TD and parkinsonism scale scores.
FH of Psychosis. Information concerning FH of psychosis among the first and second degree biological relatives was obtained from the psychiatric records, the patients themselves, their relatives, and the medical staff. A "positive FH of psychosis" was operationally defined as a first or second degree biological relative with schizophrenia or other form of psychosis (table 3) .
Neurological Abnormality. Neurological abnormality was evaluated through a standardized neurological assessment procedure consisting of 44 items, representing both soft signs (19 items from Rossi et al. 1990 ) and hard signs (25 items from Quitkin et al. 1976 , Woods et al. 1986 , and McNeil et al. 1993 ) (table 4). The 44 items encompass motor, sensory, cognitive and reflex areas, as described in detail previously (Ismail et al. 1998i>) . All of the patients and 17 of the 21 siblings had one or more signs of neurological abnormality. The quantitative scores used in data analysis represented the points for total neurological abnormality, filtered total neurological abnormality, soft signs, hard signs, filtered hard signs, and primitive reflexes. The "filtered total neurological abnormality" and "filtered hard signs" scores omitted the five items representing involuntary movements (table 4), which might overlap with the TD scale items.
Psychiatric records provided information on the duration of neuroleptic medication (lifetime exposure, measured in years), current daily neuroleptic dosage (chlorpromazine equivalents, according to Ldkemedelsboken 1997), and current use of anticholinergic medicine (present vs. absent) (table 3). All 60 patients had at some time received traditional neuroleptics, and 14 had also received atypical neuroleptics. Ten of these were receiving only atypical neuroleptics at the time of assessment (see B Results). Psychiatric records also provided information on duration of illness, measured in years from age at first psychotic episode until the time of the current examination (table 3) .
Statistical Analyses.
The association between the occurrence of TD-like dyskinesia and the risk factors/neurological abnormality was analyzed by logistic regression (SPSS 1993), using dichotomized dyskinesia (presence/absence of one or more signs of TD-like dyskinesia) as die dependent variable and the various risk factors as predictors. Similar secondary analyses (logistic regression) were done for TD dichotomized as present/absent as defined per the Schooler-Kane criteria (1982) . Spearman rank correlation was used to study the quantitative relationships between (1) total scores for TD-like dyskinesia and neurological abnormality, (2) scores for TD-like dyskinesia in the face and MPAs in the head, (3) scores for TD-like dyskinesia in the mouth/eye and MPAs in the mouth/eye, and (4) total scores for TD-like dyskinesia and parkinsonism. The Mann-Whitney-Wilcoxon test was used to compare TD scale scores for patients receiving typical versus atypical neuroleptics and to compare neurological abnormality scores for siblings with versus siblings without any signs of TD-like dyskinesia. The relationship between the occurrence of any sign of TD-like dyskinesia and the occurrence of any sign of parkinsonism was analyzed by Fisher's exact probability with odds ratios (ORs) and 95 percent confidence intervals (CIs). Statistical significance was denned as p < 0.05,2-tailed.
Results
Occurrence of TD-Llke Dyskinesia in Patients. Fortyeight (81.4%) of the patients showed at least one sign of TD-like dyskinesia; 34 (57.6%) fulfilled the SchoolerKane criteria for TD, while a further 14 (23.7%) had a pattern of one or more signs that did not fulfill the Schooler-Kane criteria. The mean total TD scale score for the patient group was 50.3 (SD = 7.5, range = 43-80).
Risk Factors and the Occurrence of TD-Like
Dyskinesia hi Patients. The presence of one or more signs of TD-like dyskinesia in patients was significantly predicted by male gender, increased rates of OCs, shorter illness duration, and shorter duration of neuroleptic medication but was unrelated to current neuroleptic dose, current anticholinergic medication, current age, FH of psychosis, head circumference at birth, and MPAs (both total MPAs and the "anomalies distribution index") (tables 5 and 6). Furthermore, no significant correlation was found between the TD-like dyskinesia score in the face (eyes, mouth, and whole face) and MPAs in the head (mouth, eyes, ears, and global head) (Spearman correlation, r s = -0.04, n = 59, ns) or, even more specifically, between the TD-like dyskinesia score for mouth and eyes and the MPA score for mouth and eyes (Spearman correlation, r s = -0.06, n = 59, ns). TD defined by the Schooler-Kane criteria was not significantly related to any of the risk factors (table 5) . Further analysis with respect to typical versus atypical neuroleptic exposure showed no significant difference in TD scale scores for the 45 patients previously exposed to only typical neuroleptics (mean = 50.5, SD = 8.3) versus the 14 also exposed to atypical neuroleptics (mean = 49.6, SD = 4.8) (Mann-Whitney U, z = -0.38, ns). A similar lack of difference in TD scale scores was found for the 33 patients currently exposed to only traditional neuroleptics (mean = 50.6, SD = 7.9) versus the 10 exposed to only atypical neuroleptics (mean = 49.9, SD = 4.3) (Mann-Whitney U, z = -0.36, ns) (excluding cases with no or mixed current medication).
Relationship Between TD-Like Dyskinesia and Neurological Abnormality hi Patients. TD-like dyskinesia and neurological abnormality showed a quantitatively positive relationship to one another, the total dyskinesia score correlating significantly with the total neurological abnormality score (Spearman rank correlation, r s = 0.38, n = 59, p = 0.003, 2-tailed). With respect to neurological subscores, the total TD-like dyskinesia score did not correlate significantly with soft neurological signs (Spearman rank correlation, r s = 0.00, n = 59, ns) or with primitive reflexes (Spearman rank correlation, r s = 0.11, n = 59, ns). In contrast, total TD-like dyskinesia correlated significantly positively with hard neurological signs (Spearman rank correlation, r s = 0.48, n = 59, p < 0.001, 2-tailed), even when involuntary movement items were removed (Spearman rank correlation, r, = 0.32, n = 59, p = 0.014, 2-tailed).
The specific hard neurological signs (excluding involuntary movements) that especially characterized patients with one or more signs of TD-like dyskinesia (n = 48) versus the remaining patients (n = 11) were deviant finger-thumb opposition (35.4% vs. 0% abnormal, and mean deviation score 0.67 vs. 0.00, in the two subgroups, respectively), mirror movements on finger-thumb opposition (35.4% vs. 9.1% abnormal, and mean deviation score 0.52 vs. 0.18, respectively), right-left confusion on the examiner (25.0% vs. 18.2% abnormal, and mean deviation score 0.50 vs. 0.27, respectively), and whole body clumsiness (25.0% vs. 9.1% abnormal, and mean deviation score 0.25 vs. 0.09, respectively).
Relationship Between TD and Parkinsonism in
Patients. At least one sign of parkinsonism was observed in 32 patients (55.2%), and the mean parkinsonism score for the total patient group was 2.0 (SD = 2.7, range = 0-11). The presence of at least one sign of TD-like dyskinesia was significantly positively associated with the presence of at least one sign of parkinsonism (Fisher's exact p = 0.049, OR = 4.3, 95% CI = 1.0-18.3), these co-occuring in 50 percent of the patients. A significant positive correlation was found between total TD scale score and total parkinsonism scale score (Spearman rank correlation, r s = 0.48, n = 58, p < 0.001, 2-tailed). In turn, parkinsonism scale scores were significantly related to total neurological abnormality (Spearman rank correlation, r s = 0.43, n = 58, p < 0.001, 2-tailed) but were unrelated to current use of anticholinergic medication (OR = 0.5, 95% CI = 0.1-1.9, ns).
TD-Like Dyskinesia in Nonpsychotic Siblings: Frequency and Relationship to Neurological Abnormality and Parkinsonism
Frequency of TD-like dyskinesia signs. Six (28.5%; four males and two females) of the 21 siblings showed one or more signs of TD-like dyskinesia, three of the siblings fulfilling the stricter Schooler-Kane criteria for TD. The mean total TD scale score for the sibling group was 44.3 (SD = 2.7, range = 43-54). For five of the six siblings with TD-like signs, at least one of the signs was given a severity rating of 3 or higher. TD-like dyskinesia signs were found in one body area in two siblings, in two body areas in three siblings, and in three body areas in one sibling. Siblings' TD-like dyskinesia was Other risk factors Note.-CI = confidence interval; MPAs = minor physical anomalies; NS = nonsignificant; OR = odds ratio; TD = tardtve dyskinesia. 1 Secondary analyses for TD defined by the Schoder-Kane criteria (1982) shown here In parentheses.
2 Analyzed as a continuous variable: logistic regression, ORs, and 95% CI, 2-tailed p value.
3 Analyzed as a dlchotomous variable: logistic regression, ORs, and 95% CI, 2-talled p value.
most frequently observed in the eyes (five siblings), mouth (three siblings), and whole face (three siblings), while only one sibling showed such dyskinesia in the upper extremities (this being in addition to dyskinesia in the eyes, mouth, and whole face for that individual).
A familial relationship between siblings' and patients' dyskinesia? The TD-like dyskinesia signs in the siblings generally differed from those in their patient brothers. Analysis of the specific signs in the six patients (all males) from the same families as the six siblings with TD-like signs revealed that one of these patients had no TD-like signs at all, two patients had many signs but no specific signs in common with those in their nonpsychotic siblings, and the remaining three patients had some but not all of the specific TD-like signs in common with their siblings in the eye and mouth regions. TD-like dyskinesia and neurological abnormality. Siblings with one or more signs of TD-like dyskinesia had a significantly higher total neurological abnormality score (mean = 6.3, SD = 4.1, n = 6) than siblings without any signs (mean = 2.7, SD = 2.9, n = 15) (Mann-WhitneyWilcoxon, z = -2.08, n = 21, p = 0.036, 2-tailed). The 15 siblings with no TD-like signs showed neurological abnormality in a total of 26 instances (items), none of which reflected involuntary movement items. In contrast, the six siblings with TD-like signs showed neurological abnormality in a total of 23 specific instances. Two of these 23 instances represented abnormal involuntary movement items. Filtering out these two items reduced the difference on neurological abnormality between siblings with versus without TD-like signs (mean = 5.7 vs. 2.7, respectively) to a nonsignificant tendency n = 2l, p = 0.154, .
Three of the 21 siblings showed one or more signs of parkinsonism. The mean parkinsonism score for the total sibling group was 0.4 (SD = 1.2, range = 0-5). Only one of the three siblings with signs of parkinsonism also had TD-like dyskinesia.
Discussion
The occurrence of one or more signs of TD-like dyskinesia in relatively young schizophrenia patients was significantly related to male gender, increased rates of OCs, and shorter duration of both the illness and exposure to neuroleptic medication. TD-like dyskinesia was unrelated to current age, neuroleptic dose level, use of anticholinergics, past or current exposure to atypical neuroleptics, and other early developmental factors such as FH of psychosis, head circumference at birth, and MPAs (the latter analyzed in four different ways). The Dublin group (Waddington et al. 1995; Lane et al. 1997) has stressed the special importance of craniofacial MPAs in schizophrenia, and other authors (Blin et al. 1989; Muscettola et al. 1990) have suggested that craniofacial TD may be a separate biological phenomenon from TD in other body regions. Nevertheless, we failed to find any relationship to MPAs even at the very specific level of facial dyskinesia or mouth and eye dyskinesia. While MPAs thus did not appear to be related to such dyskinesia in any manner, OCs clearly appeared to have greater importance for the later development of TD-like dyskinesia in the current subjects. Given the lack of consistency of OC results in previous studies (table 1) , this positive finding may be due partially to our use of data based on prospective medicalrecord information scored by the McNeil-Sjostrom OC scale. The relationship of TD-like dyskinesia to male gender is congruent with the literature (e.g., Egan et al. 1997) .
The use of less restrictive criteria than those of Schooler and Kane (1982) to define TD-like dyskinesia yielded increased insight into the background factors. Indeed, secondary analyses showed that none of the early life or current risk factors was significantly related to TD defined by the Schooler-Kane criteria (table 5) (see also Pourcher et al. 1995) . Methodological issues concerning, for instance, definition of the variables, source of information on risk factors, and patient sample characteristics may thus explain at least some of the inconsistency of results obtained in previous studies (table 1). The current results suggest that TD-like dyskinesia in these younger patients is not predominantly a side effect of neuroleptic medication, a prolonged illness process, or age itself, but rather reflects a compromised CNS, most often observed in males and seeming related to early trauma in the form of OCs.
More than one-fourth (28.6%) of the non-ill siblings showed one or more signs of TD-like dyskinesia. These signs were typically at least mild in degree, were present in several different body areas, and tended strongly to be related to other neurological abnormality in the individual. The presence of TD-like dyskinesia in non-ill biological relatives of schizophrenia patients is congruent with previous observations, both in childhood (McNeil et al. 1993 ) and later in life (McCreadie et al. 1996) . The rate in the siblings seems excessively high for individuals in this particular age range (mean = 37.9 years, range 17-51). However, the extent of possible increase above "normal levels" cannot be evaluated because of the absence of comparison figures for similarly aged normal comparison cases without FH of psychosis. Little intrafamilial concordance was found for TD-like dyskinesia in the patients and siblings in the same family, corresponding to observations of McCreadie and colleagues (1996) . A similar pattern was found for MPAs in our sample. MPAs were increased in both the current patient and sibling groups in total, but no intrafamilial relationship was found in the amount or type of MPAs in the patient and sibling in the same family .
The occurrence of signs of TD-like dyskinesia in more than one-fourth of the siblings, even in the absence of both psychosis/schizotypal personality and exposure to neuroleptic medication, suggests the influence of one or more genetic or shared environmental factors related to these movement disorders. OC data were also available for the siblings (Cantor-Graae et al. 2000) , and OC rates were increased by 65 percent in siblings with versus without any signs of TD-like dyskinesia {mean = 2.2 vs. 1.3, respectively). Total neurological abnormality was significantly related to OCs in these siblings (Cantor-Graae et al. 2000) . While these results in total might suggest that OCs contribute to both TD-like dyskinesia and neurological abnormality in a larger sense in the genetically vulnerable siblings, such conclusions should await retest of the current findings in a considerably larger sibling group with increased statistical power to detect relationships.
TD-like dyskinesia was significantly positively related to neurological abnormality in patients, and this relationship was rather specific in content The TD scale scores bore no relationship to total score for soft neurological signs (in spite of this being represented by 19 different test items, based on Rossi et al. 1990) or the score for primitive reflexes. These findings are congruent with some but not other previous results (table 2) . In contrast, scores for TD-like dyskinesia were significantly positively related to the scores for hard neurological signs (based on Quitkin et al. 1976; Woods et al. 1986; McNeil et al. 1993) , even when the involuntary movement items were removed (leaving 20 other hard sign items). The findings for the siblings showed the same general pattern but failed to reach statistical significance, possibly because of low statistical power. Second, TD scores in patients were strongly positively related to parkinsonism scores, which were also in rum related to neurological abnormality. In total, the findings suggest that TD and parkinsonism relate both to neurological abnormality and to one another positively and quantitatively, and thus seem to represent different aspects of the total neurological abnormality "phenomenon" associated with schizophrenia.
Several limitations exist for this study. The small sibling sample yielded low statistical power, and the study should be redone using a larger sample. The same examiner evaluated TD, parkinsonism, and neurological abnormality, providing the possibility of a halo effect across these three areas. Nevertheless, each area involved evaluating and scoring very specific items, high interscorer agreement was obtained for each of these areas by itself, and only specific areas of the neurological examination related significantly to TD. The absence of TD and parkinsonism scores for a normal comparison group did not make it possible to interpret the level of such signs observed especially in the non-ill siblings. Furthermore, the general validity of classifying individual neurological items as soft versus hard signs remains uncertain. This unresolved question is more a limitation for the larger neurological research area than for this study in particular. For the present analyses, we chose the operational definitional system (Rossi et al. 1990 vs. Woods et al. 1986 ) used in previous neurological studies, including the base analyses of abnormality in the current patient and sibling samples versus controls (Ismail et al. 1998b) . Most previous studies have evaluated only one "type" of neurological abnormality, and then often using relatively few items. One of the advantages of the current study is the inclusion of many items representing both putative soft and hard spheres, including primitive (developmental) reflexes. This allowed the possibility of investigating which particular components in a broader neurological assessment show a relationship to TD-like dyskinesia.
In total, the results suggest that TD-like dyskinesia at this age level is not exclusively iatrogenic or (by inference) the result of an active disease process. This dyskinesia, being common in both patient and non-ill sibling groups, reflects the influence of some shared genetic or environmental factors. The increased TD-like dyskinesia in the patients appears to be associated with OCs. This type of schizophrenia-related dyskinesia thus appears to have neurodevelopmental roots.
